Propanamide, N-[[5-[[5-fluoro-4-[[4-(2-propyn-1-yloxy)phenyl]amino]-2-pyrimidinyl]amino]-2-methylphenyl]sulfonyl]- can be used to treat diseases and disorders of the eye extracted from patent US 20140206708 A1, compound I.
[1]. Hong Ren, et al. Composition for ophthalmic administration. US 20140206708 A1.
















